 |
 |
|
JOURNAL OF BIOTECHNOLOGY
| |
| | |
|
|
|
|
|
|
Guide for Authors
JOURNAL OF BIOTECHNOLOGY
Guide for Authors
Journal of Biotechnology provides a medium for the rapid publication
of both full-length articles and short communications on all aspects of biotechnology. The Journal will accept papers ranging from genetic
or molecular biological aspects to those covering biochemical, chemical or bioprocess engineering aspects, provided that in each case
the material is directly relevant to biotechnological systems. Papers presenting information of a multi-disciplinary nature, that
would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome. The following areas
are covered by the Journal: Nucleic Acids / Molecular Biology; Physiology / Biochemistry; Biochemical Engineering / Bioprocess Engineering;
Industrial Processes / New Products; Medical Biotechnology; Agro- / Food Biotechnology.
Submission of manuscripts
Submission
of a paper to the Journal of Biotechnology implies: (1) that it is not being submitted for publication elsewhere; (2) the transfer of
the copyright from the author to the Publisher.
Authors are requested to submit their manuscripts electronically, by using the EES
online submission tool at  http://ees.elsevier.com/jbiotec/. After registration, authors will be asked to upload their article,
an extra copy of the abstract, and associated artwork. The submission tool will generate a PDF file to be used for the reviewing process.
The submission tool generates an automatic reply and a manuscript number will be generated for future correspondence.
Types of
papers
(1) Full-length papers, generally not exceeding 15 typewritten pages. Full-length papers should:
(a) be divided
into sections (Abstract, Introduction, Materials and methods, Results, Discussion);
(b) contain an Abstract, not exceeding 200 words,
at the beginning of the paper, followed by 3-6 keywords;
(c) not exceed 10-12 printed pages (approximately 15 typewritten pages) including
the space required for figures.
(2) Short Communications, not exceeding 1500 words or equivalent space including figures and
tables. These must be brief definitive reports and not preliminary findings. Short communications need not be devided into Materials
and Methods, Results and Discussion, instead, Materials and Methods may be described in the text or, if apropriate, in figure legends
or table footnotes.
(3) Reviews will be published following invitation from Editors or by the suggestion of authors.
(4) Special
Issues on highlighted aspects of biotechnology are also published. Special Issues may contain selected contributions (invited lectures)
from international conferences, or a collection of papers on a specific topic, and may be composed of review articles, research papers,
and short notes. Guest Editors responsible for the organisation of Special Issues will be invited by the Editors of the Journal, but
may also be suggested by scientists who are willing to organize a special issue on a topic that deserves publication.
(5) Letters
to the Editor and announcements of meetings and courses will be included at the discretion of the Editors and the Publisher.
Manuscripts
The manuscript should be typed with double spacing and wide margins, and should be accompanied by a separate
title page giving the authors' names and affiliations, as well as an address for correspondence including fax number and e-mail address.
If it is a resubmission this has to be indicated and the former J. Biotechnol. MS No. has to be given. All pages have to be numbered
consecutively, including the abstract, figure legends, and tables. Place the last two items after the References section. Copies of in-press
and submitted manuscripts that are important for judgement of the present manuscript should be enclosed to facilitate reviewing, and
specified as "Additional material for reviewing".
For the title, avoid numbered series titles.
In the Abstract, avoid abbreviations
and references. The Abstract should be followed by up to six Keywords.
The Material and Methods section should include sufficient
technical information to allow the experiments to be repeated. When experimental conditions are critical, give enough information to
enable another investigator to repeat the procedure. For commonly used methods a simple reference is sufficient. If several alternative
methods are described in the paper cited, please identify the method briefly in addition to the reference. Describe new methods completely.
Present the Results as concise as possible in either table(s) or figure(s). Avoid extensive use of graphs to present data that might
be more concisely presented in the text or tables. The Results and Discussion sections may be combined.
References should be assembled
on a separate page. In the text they should be referred to by name and year (Harvard System). More than one paper from the same author
in the same year must be identified by the letters a, b, c, etc., placed after the year of publication. In the text, when referring to
a work by more than two authors, the name of the first author should be given followed by et al. and year in brackets. Literature references
must consist of names and initials of all authors, year, title of paper referred to, abbreviated title of periodical, volume number and
first and last page numbers of the paper. Periodicals, books and multi-author books should follow the examples below:
Ponti, C.,
Sonnleitner, B. and Fiechter, A. (1995) Aerobic thermophilic treatment of sewage sludge at pilot plant scale. 1. Operating conditions.
J. Biotechnol. 38, 173-182. Walter, H., Brooks, D.E. and Fisher, D. (1985) Partitioning in aqueous two-phase systems. Academic Press,
Inc., Orlando, FL. Hamer, G. ( 1989) Fundamental aspects of aerobic thermophilic digestion. In: Bruce, A.M., Colin, F. and Newman, P.J.
(Eds.), Treatment of Sewage Sludge: Thermophilic Aerobic Digestion and Processing Requirements for Landfilling. Elsevier Applied Science,
London, pp. 2-19.
Abbreviations of journal titles should conform to those adopted by List of Serial Title Word Abbreviations, International
Serials Data System, 20 rue Bachaumont, 75002 Paris, France. ISBN 2- 904938-02-8.
Tables should be typed double-spaced on separate
pages, numbered consecutively with Arabic numerals, and only contain horizontal lines. A short descriptive title should appear above
each table, with possible legend and footnotes (identified with a, b, c, etc.) below.
Figures should be line drawings in black ink.
Figures should be completely labeled, the size of the lettering being appropriate to that of the drawing, taking into account the necessary
reduction in size. All legends should be typed double-spaced on separate pages. If figures are not to be reduced their format should
not exceed 16.0 x 20.2 cm. Colour reproduction is possible. Authors wishing to publish colour figures will be expected to pay for their
production costs.
Equations have to be numbered consecutively.
Nomenclature. A list of symbols and abbreviations (e.g., of enzymes)
should be provided. 'Fermentation' and 'fermenter' have become very ambiguous expressions and, therefore, should be avoided in this Journal.
Preferably use other expressions such as cultivation or bioreactor, respectively. Units and Dimensions should be expressed according
to IUPAC nomenclature, e.g.
Time, s, min, h, d, a; Mass, ng, mg, mg, g, kg, t;
Length, nm, mm, mm, cm, m, km; Volume, l, ml, ml;
Dalton, Da, for molecular mass.
Molecular weight has no dimension.
Negative powers should be used instead of fractions, e.g., g l-1 h-1,
nmol ml-1, etc.
Dimensions should not be mixed with specifications, e.g., protein per biomass (g g-1) instead of g protein/g biomass.
Scientific and Engineering Symbols. Growth kinetics and cultivation: As recommended by the International Commission at the 2nd Int.
Symposium on Cont. Cultivation of Microorganisms, Prague 1962 (Proceedings published by Academic Press, New York, p. 379, 1962). Other
symbols: as per 'Perry's Chemical Engineering Handbook'.
Exceeding tables or other additional material that should be made availabe
to the readers, may be submitted together with the manuscript and specified as "Additionl material for online publication". This will
be published in the online version of a paper, but will not appear in the printed version.
Instructions regarding GenBank/DNA
Sequence Linking:
DNA sequences and GenBank Accesion numbers: Many Elsevier journals cite "gene accession numbers" in their
running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the
database at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Elsevier authors wishing to
enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in
the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold,
underlined text. Letters in the accession number should always be capitalised. (See Example 1 below). This combination of letters
and format will enable Elsevier's typesetters to recognize the relevant texts as accession numbers and add the required link to GenBank's
sequences.
Example 1: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228, a B-cell tumor from a chronic lymphatic
leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117 )".
Authors are encouraged
to check accession numbers used very carefully. An error in a letter or number can result in a dead link. In the final version of the printed article , the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: "GenBank
accession nos. AI631510, AI631511, AI632198, and BF223228, a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048),
and a T-cell lymphoma (GenBank accession no. AA361117)".
In the final version of the electronic copy, the accession number
text will be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article.
All questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to: Elsevier Ireland
Ltd., Issue Manager Journal of Biotechnology, Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, E-mail. d.cusack@elsevier.com.
Proofs will be sent to the first-named author of an article, unless an alternative is requested on the title page of the manuscript.
They should be checked carefully and returned within 2 days of receipt. Only printer's errors may be corrected: no changes in or additions
to the edited manuscript will be allowed at this stage.
Page charges will not be made.
Reprints may be ordered by filling
in and returning to the Publishers the order form sent to the author with the proofs. Twenty-five free offprints per contribution will
be made available.
|
|
|
|
| |
| | |
|
| |
